Vinay Prasad, MD MPH
September 1st, 2014
Let’s Take a Close Look at PARADIGM-HF
Vinay Prasad, MD MPH
Vinay Prasad explores three reasons why clinicians should have reservations about the findings from PARADIGM-HF.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?